Ingersoll Rand Inc. (IR) Stock Price & Analysis
Ingersoll Rand Inc. (IR) is trading at USD 73.45, down 0.89% today, as of October 23, 2026 at 15:45 UTC (US market open; quotes may be delayed), according to Nexqual market data.
IR last closed at USD 74.11; today's session has ranged USD 72.36–74.14 on volume of 1,228,436 shares. Market capitalization is $28.50B, with a 52-week range of USD 68.07–100.96 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 15:45 UTC.
Also available as compact Markdown for AI agents: nexqual.com/IR.md
Key facts (IR)
- Last four reported quarters (through Jun 30, 2026): revenue $7.94B, net income $959M (12.1% margin), free cash flow $1.22B (SEC filings).
- Valuation: P/E 29.7x (avg 46.4x at the last 3 fiscal year-ends), EV/EBITDA 16.3x, net debt $3.60B.
- 2 of 80 tracked superinvestors hold IR (13F, Q2 2026): 0 new, 2 added, 0 reduced, 0 unchanged.
- Insider open-market sales, last ~7 months: 1 Form 4 filings, $2.7M; 0 not under a Rule 10b5-1 plan ($0K); 1 by opportunistic insiders (0 outside 10b5-1 plans), 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Insider open-market purchases, last ~7 months: 1 Form 4 filing, $1.0M; 0 by opportunistic insiders, 0 by routine insiders.
- Analysts: Hold (mean 2.50 on a 1–5 scale) (14 analysts), mean target USD 94.1 (range 82–109).
- Total return with dividends: 1Y -8.5% vs S&P 500 +14.7%; 5Y +37.4% vs S&P 500 +77.4%.
- Next earnings: 2026-10-29, EPS estimate USD 0.9, revenue estimate $2.05B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (IR)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $5.15B | $5.92B | $6.88B | $7.24B | $7.65B | $7.94B |
| Gross profit | $1.99B | $2.33B | $2.88B | $3.17B | $3.34B | — |
| Operating income | $566M | $817M | $1.16B | $1.30B | $1.14B | $1.44B |
| Net income | $563M | $605M | $779M | $839M | $581M | $959M |
| EPS (diluted) | $1.34 | $1.47 | $1.90 | $2.06 | $1.45 | — |
| Free cash flow | $564M | $771M | $1.27B | $1.25B | $1.22B | $1.22B |
| Gross margin | 38.6% | 39.3% | 41.9% | 43.8% | 43.6% | — |
| Operating margin | 11.0% | 13.8% | 16.9% | 18.0% | 15.0% | 18.1% |
| Net margin | 10.9% | 10.2% | 11.3% | 11.6% | 7.6% | 12.1% |
| Revenue growth | +29.7% | +14.8% | +16.2% | +5.2% | +5.7% | — |
| Cash + short-term investments | $2.11B | $1.61B | $1.60B | $1.54B | $1.25B | — |
| Total debt | $2.82B | $2.75B | $2.72B | $4.76B | $4.78B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (IR)
P/E 29.7x · P/S 3.6x · EV/EBITDA 16.3x · EV/Sales 4.0x · P/FCF 23.4x · P/B 2.8x · FCF yield 4.28% · Earnings yield 3.37% · Dividend yield (paid, TTM) 0.11% · Buyback yield (TTM) 2.97% · Net debt $3.60B · EV $32.1B
P/E at fiscal year-ends: Dec 2025 54.6x, Dec 2024 43.9x, Dec 2023 40.6x.
Superinvestors (SEC 13F-HR, Q2 2026) (IR)
2 of 80 tracked investors hold IR. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Sarah Ketterer | Causeway Capital Management | 0.92% | $84.8M | Added +65.1% |
| Wallace Weitz | Weitz Investment Management | 0.92% | $13.3M | Added +21.4% |
Insider sales (SEC Form 4, open-market, last ~7 months) (IR)
1 of 1 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-04-13 | Reynal Vicente | See Remarks | 30,492 | $2.7M | 7.9% | Yes (adopted May 22, 2025) | Opportunistic (traded every year 2023–2025, no repeating month) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Insider purchases (SEC Form 4, open-market, last ~7 months) (IR)
1 purchase, $1.0M. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-08-03 | Satpathy Aurobind | Director | 11,538 | $1.0M | 86.68 | Too little history (no open-market trades in 2023–2025) |
Analysts (IR)
Consensus Hold (mean 2.50 on a 1–5 scale), 14 analysts; mean target USD 94.1 (low 82, high 109).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-11 | Evercore ISI Group | Target raised | In-Line | $84 → $93 |
| 2026-08-03 | Baird | Target raised | Outperform | $103 → $109 |
| 2026-07-20 | Stifel | Target lowered | Hold | $85 → $84 |
Total return (dividends reinvested) (IR)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | -8.5% | +37.4% |
| S&P 500 (SPY) | +14.7% | +77.4% |
| Per year | -8.5% | +6.6% |
| Volatility (annualized) | 32.9% | 30.0% |
| Max drawdown | -30.6% (Feb 2026→May 2026) | -33.7% (Dec 2021→Jul 2022) |
IR revenue by business segment (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Industrial Technologies and Services | $1.62B | 79.2% | +8.7% |
| Precision and Science Technologies | $426.7M | 20.8% | +7.7% |
| Total revenue | $2.05B | 100% | — |
IR revenue by product line (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Original equipment | $975.2M | 47.6% | +10.2% |
| Aftermarket | $646.9M | 31.6% | +6.6% |
| Total revenue | $2.05B | 100% | — |
IR revenue by region (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Americas | $979.7M | 47.8% | +2.6% |
| — U.S. Plans (part of Americas) | $809.5M | 39.5% | +1.4% |
| — Other Americas (part of Americas) | $170.2M | 8.3% | +8.7% |
| EMEIA | $674.3M | 32.9% | +10.4% |
| Total Asia Pacific | $394.8M | 19.3% | +22.6% |
| — China (part of Total Asia Pacific) | $248.0M | 12.1% | +18.9% |
| — Other Asia Pacific (part of Total Asia Pacific) | $146.8M | 7.2% | +29.5% |
| Total revenue | $2.05B | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
IR suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Competitor | Thermo Fisher (TMO) | “Our primary competitors include Dover, Graco, IDEX Corporation, KNF Neuberger, Netzsch, NOV, Sartorius, SPX Flow, Thermo Fisher Scientific, and Watson-Marlow, as well as other regional and local manufacturers.” |
Quoted from the company's 10-K filed Feb 17, 2026.
IR company outlook (results filed Jul 30, 2026)
- “Guidance 4,5,6,7 Ingersoll Rand is updating its full-year 2026 guidance.”
Quoted word-for-word from the SEC 8-K results press release.
IR analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.90 | $0.91 | -0.6% | $2.05B | 13 |
| Next quarter (ends Dec 2026) | $1.02 | $1.00 | +1.7% | $2.17B | 12 |
| Current fiscal year (ends Dec 2026) | $3.55 | $3.50 | +1.4% | $8.12B | 14 |
| Next fiscal year (ends Dec 2027) | $3.91 | $3.85 | +1.5% | $8.52B | 14 |
IR options: expected move
Options price a move of about ±10.6% (±$7.80) by Nov 20, 2026, which includes earnings on Oct 29, 2026. Over the last 8 reports the stock moved ±4.9% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 28 | 47.0% | ±10.6% |
| Dec 18, 2026 | 56 | 35.6% | ±11.3% |
| Jan 15, 2027 | 84 | 35.7% | ±13.8% |
| Mar 19, 2027 | 147 | 34.7% | ±17.7% |
| Jun 17, 2027 | 237 | 36.5% | ±23.4% |
| Sep 17, 2027 | 329 | 35.9% | ±26.9% |
30-day implied volatility 45.2% vs 29.1% realized over the last 30 trading days. Put/call ratio (volume) 6.6. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 15:45 UTC)
| Price | USD 73.45 |
|---|---|
| Change | ▼ 0.89% (down) |
| Previous Close | USD 74.11 |
| Open | USD 73.56 |
| Day Range | USD 72.36 – 74.14 |
| 52-Week Range | USD 68.07 – 100.96 |
| Volume | 1,228,436 shares |
| Market Cap | $28.50B |
| Exchange | NYQ |
Technical Analysis (IR)
Nexqual's technical model rates IR "SELL" based on 2 bullish and 5 bearish signals across 128 daily candles, as of October 23, 2026 at 15:45 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 37.27 (neutral) |
| vs SMA50 | Below (USD 76.71) |
| MACD | -0.09 (negative) |
Analyst Ratings (IR)
Wall Street analysts rate IR "Hold" based on 14 analysts, with a mean price target of USD 94.1 (range USD 82–109), per Nexqual as of October 23, 2026 at 15:45 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 14 |
| Mean Target | USD 94.1 |
| High Target | USD 109 |
| Low Target | USD 82 |
| Buy / Hold / Sell | 7 / 7 / 0 |
Earnings (IR)
| Next Earnings Date | 2026-10-29 |
|---|---|
| EPS Estimate | USD 0.9 |
| Revenue Estimate | $2.05B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.86 vs est 0.83 ▲ beat |
| 2026-03-31 | USD 0.77 vs est 0.74 ▲ beat |
| 2025-12-31 | USD 0.96 vs est 0.9 ▲ beat |
| 2025-09-30 | USD 0.86 vs est 0.86 ▼ miss |
Source: Nexqual, October 23, 2026 at 15:45 UTC.
Financials & Fundamentals (IR)
| Total Revenue | $7.94B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +8.50% |
| Gross Margin | +42.82% |
| Operating Margin | +16.88% |
| Profit Margin | +12.08% |
| ROE | +9.47% |
| Debt / Equity | 0.48 |
| Current Ratio | 1.62 |
| Total Cash | $1.18B |
| Total Debt | $4.91B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $1.22B (15.4% of revenue) |
Source: Nexqual, October 23, 2026 at 15:45 UTC.
Financial Health Score (IR)
Nexqual rates Ingersoll Rand Inc.'s overall financial health "Solid" across five dimensions, as of October 23, 2026 at 15:45 UTC.
| Growth | Solid — Revenue +6% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 43%, operating 17% (last 12 months) |
| Balance Sheet | Solid — $1.17B cash and investments vs $4.77B debt (Jun 2026, SEC) |
| Cash Flow | Strong — FCF $1.22B (last 4 quarters to Jun 2026, SEC), 15% margin |
| Efficiency | Mixed — ROE 9%, ROA 5.1% |
Ownership (IR)
| Insider Ownership | +0.21% |
|---|---|
| Institutional Ownership | +106.03% |
| Shares Outstanding | 388.00M |
| Float | 386.76M |
| Short % of Float | +3.98% |
Source: Nexqual, October 23, 2026 at 15:45 UTC.
Leadership (IR)
Ingersoll Rand Inc. is led by Vicente Reynal, Chairman, CEO & President, per Nexqual as of October 23, 2026 at 15:45 UTC.
| Chairman, CEO & President | Vicente Reynal |
|---|---|
| Senior VP & CFO | Vikram U. Kini |
| Senior Vice President of Ingersoll Rand Execution Excellence (IRX), Business & Commercial Excellence | Michael A. Weatherred |
| Senior Vice President of Corporate Development | Elizabeth Meloy Hepding |
Major Backers & Investors (IR)
Notable institutional backers of Ingersoll Rand Inc. include Capital Group, Price (T.Rowe) Associates Inc, T. Rowe Price, according to Nexqual as of October 23, 2026 at 15:45 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Capital Group | 13.7% |
| Price (T.Rowe) Associates Inc | 6.97% |
| T. Rowe Price | 4.14% |
| Franklin Resources, Inc. | 3.98% |
| FMR, LLC | 3.42% |
| Investment Co of America | 2.31% |
| Amcap Fund | 1.66% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 10.65% |
| BlackRock | 7.81% |
| State Street | 4.1% |
Source: Nexqual, October 23, 2026 at 15:45 UTC.
From Ingersoll Rand Inc.'s Latest SEC 10-K Filing (filed 2026-02-17)
Key Strengths & Strategy (as disclosed to the SEC)
- Our products are sold under more than 90 market-leading brands, including Ingersoll Rand and Gardner Denver, which we believe are globally recognized in their respective end-markets and known for product quality, reliability, efficiency and superior customer service.
- The acquisition will enable Ingersoll Rand to combine several technologies like low pressure compressors with SSI's aeration offerings to provide a comprehensive, end-to-end solution. •In July 2025, the Company completed the acquisition of Termomeccanica Industrial Compressors S.p.A. ("TMIC") and its subsidiary Adicomp S.p.A. ("Adicomp") (collectively "TMIC/Adicomp") for cash consideration of $193.2 million.
- We manufacture one of the broadest and most complete ranges of compressor, pump, vacuum and blower products in our markets, which, when combined with our global geographic footprint and application expertise, allows us to provide differentiated product and service offerings to our customers.
Partnerships
- We collaborate with universities, key industry, and professional organizations, such as Disability IN, the Society of Hispanic Professional Engineers, National Black MBA Association and Women in Manufacturing, to recruit early and mid-level talent.
Legal & Regulatory Risks (Item 1A, quoted)
- The nature of our products creates the possibility of significant product liability, warranty claims, and product recalls, which could harm our business.
- Changes in tax laws and regulations, or adverse determinations by taxing or other governmental authorities could increase our effective tax rate and cash taxes paid or otherwise affect our financial condition or operating results.
- The risk of non-compliance with U.S. and foreign laws and regulations applicable to our international operations could have a significant impact on our results of operations, financial condition or strategic objectives.
- Environmental compliance costs and liabilities could adversely affect our financial condition.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OTIS | Otis Worldwide Corporation | USD 74.99 | ▼ 0.81% |
| DOV | Dover Corporation | USD 197.54 | ▲ 1.05% |
| XYL | Xylem Inc. | USD 109.3 | ▲ 0.04% |
| NDSN | Nordson Corporation | USD 319.39 | ▲ 0.21% |
| ROK | Rockwell Automation, Inc. | USD 426.18 | ▲ 0.54% |
| ITT | ITT Inc. | USD 189.13 | ▲ 0.46% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 15:45 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt